But using cells drawn from umbilical cord blood, Rezvani’s team have been able to manufacture around 40 million CD19-targeting chimeric natural killer cells in two weeks. She told the conference ...

mature NK cells were rapidly generated, indicative of a high capacity for maturation, like that observed in adult peripheral blood. In agreement with these phenotypic observations, NK cells are ...

For a source of NK cells, Rezvani turned to umbilical-cord blood. This source provides a large number of NK cells from healthy individuals, which work better than those from patients with cancer.